NCT07023120View on ClinicalTrials.gov

PENG Block Optimization: Volume and Dexamethasone Effects

PHASE4RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 25, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 1, 2026

Conditions
Hip ArthropathyHip OsteoarthritisHip Arthritis
Interventions
DRUG

Ropivacaine 0.2% Injectable Solution

20ml 0.2% Ropivacaine

DRUG

Dexamethasone 4mg

perineural 4mg Dexamethasone

DRUG

Ropivacaine 0.2% Injectable Solution

10ml 0.2% Ropivacaine

Trial Locations (1)

Unknown

RECRUITING

Poznan University of Medical Sciences, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER